These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10654540)

  • 1. Bridge to recovery with a left ventricular assist device for fulminant acute myocarditis.
    Ueno T; Bergin P; Richardson M; Esmore DS
    Ann Thorac Surg; 2000 Jan; 69(1):284-6. PubMed ID: 10654540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TandemHeart pVAD in the treatment of acute fulminant myocarditis.
    Khalife WI; Kar B
    Tex Heart Inst J; 2007; 34(2):209-13. PubMed ID: 17622371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful management of fulminant myocarditis with left ventricular assist device: report of a severe case.
    Unosawa S; Hata M; Sezai A; Niino T; Yoshitake I; Shimura K; Takamori T; Minami K
    Ann Thorac Cardiovasc Surg; 2010 Aug; 16(1):48-51. PubMed ID: 20190711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bridge-to-recovery from acute myocarditis in a 12-year-old child.
    Hotz H; Linneweber J; Dohmen PM; Vargas O; Braun J; Konertz W
    Artif Organs; 2004 Jun; 28(6):587-9. PubMed ID: 15153152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A new percutan assist device for treatment of fulminant myocarditis].
    Lindholm MG; Engstrøm T; Boesgaard S; Hassager C
    Ugeskr Laeger; 2007 Sep; 169(39):3303-4. PubMed ID: 17953892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First successful bridge to recovery with the Impella Recover 100 left ventricular assist device for fulminant acute myocarditis.
    Colombo T; Garatti A; Bruschi G; Lanfranconi M; Russo C; Milazzo F; Catena E; Frigerio M; Vitali E
    Ital Heart J; 2003 Sep; 4(9):642-5. PubMed ID: 14635384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paracorporeal pulsatile biventricular assist device versus extracorporal membrane oxygenation-extracorporal life support in adult fulminant myocarditis.
    Pages ON; Aubert S; Combes A; Luyt CE; Pavie A; Léger P; Gandjbakhch I; Leprince P
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):194-7. PubMed ID: 19154925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facilitated cardiac recovery in fulminant myocarditis: pediatric use of the Impella LP 5.0 pump.
    Andrade JG; Al-Saloos H; Jeewa A; Sandor GG; Cheung A
    J Heart Lung Transplant; 2010 Jan; 29(1):96-7. PubMed ID: 19782584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the Impella 5.0 Device as a Bridge to Recovery in Adult Fulminant Viral Myocarditis.
    Burns DJ; Quantz MA
    Innovations (Phila); 2015; 10(4):279-81. PubMed ID: 26368033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term use of ventricular assist device as a bridge to recovery in acute fulminant myocarditis.
    George CL; Ameduri RK; Reed RC; Dummer KB; Overman DM; St Louis JD
    Ann Thorac Surg; 2013 Mar; 95(3):e59-60. PubMed ID: 23438564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful bridge to recovery in fulminant myocarditis using a biventricular assist device: a case report.
    Adachi Y; Kinoshita O; Hatano M; Shintani Y; Naito N; Kimura M; Nawata K; Nitta D; Maki H; Ueda K; Amiya E; Takimoto E; Komuro I; Ono M
    J Med Case Rep; 2017 Oct; 11(1):295. PubMed ID: 29061186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thoratec left ventricular assist device for bridging to recovery in fulminant acute myocarditis.
    Joharchi MS; Neiser U; Lenschow U; Schubert J; Kienast W; Noeldge-Schomburg G; Steinhoff G
    Ann Thorac Surg; 2002 Jul; 74(1):234-5. PubMed ID: 12118766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined use of Impella left ventricular assist device and extracorporeal membrane oxygenation as a bridge to recovery in fulminant myocarditis.
    Chaparro SV; Badheka A; Marzouka GR; Tanawuttiwat T; Ahmed F; Sacher V; Pham SM
    ASAIO J; 2012; 58(3):285-7. PubMed ID: 22395121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Clinical Potential of Impella 5.0 Support in the Treatment of Recurrent Fulminant Viral Myocarditis with Profound Cardiogenic Shock.
    Ogawa S; Suzuki M; Ochi H; Saji M; Mahara K; Takamisawa I; Nishigawa K; Furuichi Y; Takanashi S; Isobe M
    Intern Med; 2019 May; 58(10):1459-1462. PubMed ID: 30626823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart Transplantation Under Mechanical Circulatory Support for Acute Fulminant Myocarditis With Cardiogenic Shock: 10 Years' Experience of a Single Center.
    Ting M; Wang CH; Tsao CI; Huang SC; Chi NH; Chou NK; Chen YS; Wang SS
    Transplant Proc; 2016 Apr; 48(3):951-5. PubMed ID: 27234777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis.
    den Uil CA; Akin S; Jewbali LS; Dos Reis Miranda D; Brugts JJ; Constantinescu AA; Kappetein AP; Caliskan K
    Eur J Cardiothorac Surg; 2017 Jul; 52(1):14-25. PubMed ID: 28472406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanical circulatory support for patients with acute-fulminant myocarditis.
    Acker MA
    Ann Thorac Surg; 2001 Mar; 71(3 Suppl):S73-6; discussion S82-5. PubMed ID: 11265870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of myocardial recovery in a patient with acute myocarditis supported with a left ventricular assist device: a case report.
    Maybaum S; Stockwell P; Naka Y; Catanese K; Flannery M; Fisher P; Oz M; Mancini D
    J Heart Lung Transplant; 2003 Feb; 22(2):202-9. PubMed ID: 12581771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful explantation of a left ventricular assist device following acute fulminant myocarditis.
    El-Hamamsy I; White M; Pellerin M; Demers P; Bouchard D; Leung TK; Perrault LP; Carrier M
    Can J Cardiol; 2006 May; 22(6):507-8. PubMed ID: 16685316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation.
    Asaumi Y; Yasuda S; Morii I; Kakuchi H; Otsuka Y; Kawamura A; Sasako Y; Nakatani T; Nonogi H; Miyazaki S
    Eur Heart J; 2005 Oct; 26(20):2185-92. PubMed ID: 16014643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.